Founder of MedSpa Walden Cosmetic Surgery and Laser Center, Dr. Jennifer Walden, is a world renown aesthetic plastic surgeon. In an industry that consists mostly of male doctors, Dr. Walden has made an impact and continues to leave her mark. Her practice, which she has relocated to her home state of Texas from New York where she received her specialized training, is made up of all women as well as catering to mainly female patients. The doctor and her staff pride themselves on the fact that they are a firm run by women, for women, in a mainly male field. It is not hard to guess that they enjoy the feeling of empowering other women.
Procedures offered at MedSpa Walden Cosmetic Surgery and Laser Center include but are not limited to face, breast, body, hair restoration, radio frequency treatments, injecatable treatments, skin treatments, femtouch laser, laser vaginal tightening, laser tattoo removal, non-invasive fat elimination, broadband light based treatments, and IV hydration therapy. Costs for procedures and treatments range from hundreds to thousands of dollars.
Dr. Walden studied as a plastic surgeon at Manhattan Eye, Ear, and Throat Hospital as well as Lenox Hill Hospital, both located in New York. Academic appointments after graduating as an accredited surgeon have included Instructor of Surgery at the New York University Langone Medical Center’s Department of Plastic Surgery and currently she is a Clinical Assistant Professor in Plastic Surgery at The University of Texas Southwestern.
Dr. Walden is on the Board of Directors for the American society for Aesthetic Plastic Surgery, and currently holds the position of Commissioner of Communications for organization as well as acting as their media spokesperson. She has been recognized as a Texas Super Doctor (2014), a Castle Connelly’s Top Doctors (2016), and one of 24 Best Beauty Surgeons in the United States by Harper’s Bazaar magazine (2014). She is also the author of several award-winning articles and research papers, and learn more about Dr. Walden.
Multiple Sclerosis is a disease that has the body’s immunity system attacking, and disabling the central nervous system (CNS). A clinical trial study named on the disease dubbed, HALT-MS, revealed that a high dosage of drugs that suppress the strength of the immunity system, coupled with a blood stem transplant, increase the chances of the sustained remission.
The NIAID, which is connected to the National Institute of Health sponsored the trial. It was coordinated by ITN which is funded by NIAID.
The trail study noted that sixty-nine percent of the people that participated in the pilot study did not experience progressive disability, new brain lesions or even relapse of the MS symptoms, five years after receiving the treatment.
The treatment is known as HDIT/HCT i.e. therapy that inhibits the activity in the immune system, and autologous cell transplanting in large doses. The study also observed that after going through the HDIT/HCT treatment, the participants did not need to continue taking any medication.
The trial treatment is centered on reducing the activity of the disease and eliminating the possibility of the CNS being disabled by this activity. This was done by the removal of the disease-inducing cells and rebooting the immune system by transplanting a participant’s blood-making stem cells.
The study has made tremendous success in stabilizing MS to date and reveal that HDIT/HCT can become a potential solution to people with relapsing-remitting multiple sclerosis.
Shiva Gopal Vasishta
Dr. Shiva Gopal Vasishta is well known for his specialty and contributions in Neurology globally. Dr. Gopal is also licensed to practice Psychiatry in Voorhees, New Jersey. He attained his medical degree from Government Medical College in 1979.
Dr. Shiva Gopal Vasishta went through his residency at Boston City Hospital and has over 40 years of medical excellence to date.
He currently operates his practice at Eastern Neurodiagnostic Associate. Dr. Shiva Gopal Vasishta is recognized for his affiliations with Kennedy Health System Cherry Hill where he is making significant contributions to the neurological field.